DOYLESTOWN, Pa., Jan. 26, 2017 -- Crawford Healthcare, Inc. (“Crawford” or the “Company”) announced today the signing of a national group purchasing agreement with Premier Inc. (“Premier”), a leading healthcare improvement company. This three-year award includes both the Primary/Secondary wound care dressings and wound debridement category and the skin cleansers, barrier and lotion products category. Effective April 1st, these two categories will allow Crawford’s full portfolio of products to be offered at specially negotiated pricing and terms to members of Premier’s alliance, which includes 3,750 hospitals and 130,000 other providers. Premier operates one of the largest healthcare group purchasing organizations (GPOs) in the United States.
Crawford’s innovative line of advanced wound and skin care products was designed with novel technologies to advance the standard of care in the exudate management, infection control and skin protection segments. This national agreement combines Crawford’s products with Premier’s integrated data and analytics, collaboratives, supply chain solutions, advisory and other services to enable better care and outcomes at a lower cost.
“This new contract award is a testament to the clinical acceptance of Crawford’s portfolio and our growth within Premier alliance hospitals over the past year. We look forward to the opportunity to partner with more Premier members who share our values and are striving to overcome the clinical and economic challenges that everyone is facing,” says Terry Bromley, Senior Vice President and General Manager of Crawford’s U.S. operations.
For more information about Crawford Healthcare, Inc. or its products, please visit http://crawfordhealthcare.us/
About Crawford Healthcare, Inc.
Crawford Healthcare, Inc., is a rapidly growing international company dedicated to developing innovative treatments and effective dermatological, wound care, and diagnostic products for the care and repair of skin. The Company has worked closely with healthcare professionals for more than 15 years from the international head office of its parent company, Crawford Healthcare Holdings Limited (the “Crawford Group”), in Knutsford, Cheshire, U.K. In early 2013, the Crawford Group expanded its operations and opened a United States office in Doylestown, Pa., that focuses on the Company’s portfolio of advanced wound care products. To help lead its U.S. business, the Crawford Group has assembled a skilled management team with long-standing industry backgrounds in the advanced wound care arena. The team offers more than 150 years of collective experience in the field and has deployed a nationwide direct sales team dedicated to wound, skin, and burn care.
Contact: Terry Bromley Senior Vice President & General Manager Crawford Healthcare, Inc. 267.532.1284 [email protected]


Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Britain Courts Anthropic Amid US Defense Department Dispute
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
First Western Ship Transits Strait of Hormuz Since Iran War Began
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook 



